Form 4: GE HealthCare CEO Sells Shares for Tax Obligations

GE HealthCare Technologies Inc. President and CEO, Peter J. Arduini, disposed of 11,346 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Peter J. Arduini, President and CEO, and Director of GE HealthCare Technologies Inc. (GEHC), reported the disposition of common stock.
• The transactions occurred on September 1, 2025, and were made pursuant to a Rule 10b5-1(c) plan.
• A total of 11,346 shares of common stock were disposed of in two separate transactions: 5,874 shares and 5,472 shares.
• The shares were disposed of at a price of $73.73 per share.
• The purpose of the disposition was to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
• Following these transactions, Peter J. Arduini directly beneficially owns 167,882 shares of GE HealthCare common stock.

Sentiment

Score: 5

Explanation: Neutral. This is a routine, non-discretionary transaction for tax purposes, not indicative of management's view on the company's future prospects or operational performance.

Positives

• The disposition of shares was a non-discretionary transaction to cover tax withholding obligations, not a voluntary sale indicating a lack of confidence.
• The transaction was executed under a Rule 10b5-1(c) plan, demonstrating adherence to corporate governance best practices.
• Peter J. Arduini retains a significant beneficial ownership of 167,882 shares, indicating continued alignment with shareholder interests.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it pertains solely to a past insider transaction.

Management Comments

• The disposition of shares of GE HealthCare Technologies Inc. common stock was to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Industry Context

This type of insider transaction, involving the disposition of shares to cover tax liabilities upon the vesting of equity awards, is a common and routine event across all industries for executives receiving stock-based compensation. It does not reflect specific industry trends or competitive positioning.

Comparison to Industry Standards

• The practice of executives selling shares to cover tax obligations upon equity vesting is standard across publicly traded companies, including peers in the healthcare technology sector such as Siemens Healthineers AG or Philips NV.
• The use of a Rule 10b5-1(c) plan for such transactions aligns with best practices for insider trading compliance, similar to those adopted by executives at leading global corporations.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal direct impact, as this is a routine tax-related transaction. The CEO's continued significant ownership may be viewed positively.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific filing.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary sale of shares by the CEO to cover tax obligations upon the vesting of restricted stock units. It does not reflect a change in management's outlook or a strategic shift, nor does it indicate a lack of confidence. The CEO retains a substantial holding in the company. Therefore, the filing itself provides no new information to warrant a change in investment recommendation, suggesting a 'hold' position based solely on this specific report.

Keywords

GE HealthCare Technologies, GEHC, Peter J. Arduini, Insider Transaction, Form 4, Stock Disposition, Tax Withholding, Restricted Stock Units, CEO Stock Sale, Corporate Governance